Cite
Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study.
MLA
Kuo, Feng-Yu, et al. “Effect of CYP2C19 Status on Platelet Reactivity in Taiwanese Acute Coronary Syndrome Patients Switching to Prasugrel from Clopidogrel: Switch Study.” Journal of the Formosan Medical Association = Taiwan Yi Zhi, vol. 121, no. 9, Sept. 2022, pp. 1786–97. EBSCOhost, https://doi.org/10.1016/j.jfma.2022.01.013.
APA
Kuo, F.-Y., Lee, C.-H., Lan, W.-R., Su, C.-H., Lee, W.-L., Wang, Y.-C., Lin, W.-S., Chu, P.-H., Lu, T.-M., Lo, P.-H., Tsukiyama, S., Yang, W.-C., Cheng, L.-C., Huang, C.-L., Yin, W.-H., & Liu, P.-Y. (2022). Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study. Journal of the Formosan Medical Association = Taiwan Yi Zhi, 121(9), 1786–1797. https://doi.org/10.1016/j.jfma.2022.01.013
Chicago
Kuo, Feng-Yu, Cheng-Han Lee, Wei-Ren Lan, Cheng-Huang Su, Wen-Lieng Lee, Yi-Chih Wang, Wei-Shiang Lin, et al. 2022. “Effect of CYP2C19 Status on Platelet Reactivity in Taiwanese Acute Coronary Syndrome Patients Switching to Prasugrel from Clopidogrel: Switch Study.” Journal of the Formosan Medical Association = Taiwan Yi Zhi 121 (9): 1786–97. doi:10.1016/j.jfma.2022.01.013.